Robbins Geller Will Lead Proposed Inovio Investor Class
Robbins Geller Rudman & Dowd LLP, with an assist from Saxton & Stump, will represent a proposed class of shareholders in a suit alleging Inovio Pharmaceuticals Inc. inflated its stock price...To view the full article, register now.
Already a subscriber? Click here to view full article